R.i.a.() -

The acronym most commonly refers to Radioimmunoassay , a highly sensitive laboratory technique used to measure concentrations of substances like hormones or vitamins. However, depending on the context, it can also represent financial, regulatory, or technical terms. 1. Radioimmunoassay (Science & Medicine)

In the financial sector, an RIA is a professional firm that manages assets for individuals or institutions. R.I.A.()

: After incubation, bound and free antigens are separated. The remaining radioactivity is measured, typically with a gamma counter; the higher the radioactivity, the lower the concentration of the substance in the sample. The acronym most commonly refers to Radioimmunoassay ,

Developed in the late 1950s by Solomon Berson and Rosalyn Yalow, RIA revolutionized medical diagnostics by allowing the measurement of minute quantities of antigens (like insulin) in the blood. Developed in the late 1950s by Solomon Berson

: It uses competitive binding , where a known amount of radiolabeled antigen competes with unlabeled antigen from a patient's sample for a limited number of antibody binding sites.